Brokerages Set Endava plc (NYSE:DAVA) PT at $39.10

Endava plc (NYSE:DAVAGet Free Report) has received a consensus rating of “Moderate Buy” from the eleven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $39.10.

Several equities analysts have commented on DAVA shares. Needham & Company LLC dropped their price target on shares of Endava from $43.00 to $38.00 and set a “buy” rating for the company in a research note on Friday, February 21st. Susquehanna lowered their target price on Endava from $55.00 to $50.00 and set a “positive” rating for the company in a research note on Friday, February 21st. Finally, Morgan Stanley increased their price target on Endava from $33.00 to $35.00 and gave the company an “equal weight” rating in a research report on Friday, January 31st.

Get Our Latest Analysis on DAVA

Endava Price Performance

DAVA opened at $20.70 on Tuesday. The stock’s 50-day moving average price is $27.56 and its 200 day moving average price is $27.97. Endava has a 12-month low of $20.38 and a 12-month high of $38.42. The firm has a market cap of $1.22 billion, a price-to-earnings ratio of 188.18, a PEG ratio of 2.26 and a beta of 1.42. The company has a current ratio of 1.90, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21.

Endava (NYSE:DAVAGet Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.18). The business had revenue of $250.63 million for the quarter, compared to analyst estimates of $197.33 million. Endava had a return on equity of 0.89% and a net margin of 0.74%. As a group, sell-side analysts expect that Endava will post 0.57 earnings per share for the current year.

Institutional Investors Weigh In On Endava

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Assetmark Inc. boosted its stake in Endava by 93.1% in the fourth quarter. Assetmark Inc. now owns 985 shares of the company’s stock valued at $30,000 after acquiring an additional 475 shares in the last quarter. Quadrant Capital Group LLC boosted its position in shares of Endava by 114.2% in the 4th quarter. Quadrant Capital Group LLC now owns 1,474 shares of the company’s stock valued at $46,000 after purchasing an additional 786 shares during the period. Blue Trust Inc. grew its stake in Endava by 28.5% during the 4th quarter. Blue Trust Inc. now owns 1,494 shares of the company’s stock worth $46,000 after buying an additional 331 shares during the last quarter. GAMMA Investing LLC increased its position in Endava by 86.4% during the fourth quarter. GAMMA Investing LLC now owns 1,607 shares of the company’s stock worth $50,000 after buying an additional 745 shares during the period. Finally, State of Tennessee Department of Treasury purchased a new stake in Endava in the fourth quarter valued at approximately $100,000. 62.23% of the stock is currently owned by institutional investors and hedge funds.

Endava Company Profile

(Get Free Report

Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.

Recommended Stories

Analyst Recommendations for Endava (NYSE:DAVA)

Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.